Navigation Links
Yasmin, Yaz Alleged Blood-Clotting Lawsuits Update: Resource4thePeople Reports Bayer Settles Nearly 5,000 Cases for $1 Billion and also now Settling Gall Bladder Cases
Date:4/27/2013

San Diego, CA (PRWEB) April 27, 2013

http://www.resource4thepeople.com/defectivedrugs/yasmin.html

Resource4thePeople is updating consumers today with news about the progress of consolidated federal court lawsuits* claiming that the popular birth control pills Yaz and Yasmin allegedly can cause blood-clotting problems that plaintiffs claim may be life-threatening.

Germany pharmaceutical giant Bayer has detailed in its annual report** that it has settled about 4,800 of these lawsuits for over $1 billion and that there are over 13,000 claimants still seeking damages over side effects, reports Resource4thePeople.

"As of February 12, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 4,800 claimants in the U.S. for a total amount of about US$1 billion," according to the annual report.

Bayer also said that it, "is only settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case-specific analysis of medical records on a rolling basis. Such injuries are alleged by about 3,200 of the pending unsettled claimants. Bayer will continue to consider the option of settling individual lawsuits in the U.S. on a case-by-case basis."

Resource4thePeople is also updating consumers with news that Bayer also has agreed to pay up to $24 million to settle other lawsuits involving allegations over gall bladder side effects.These settlements are a different part of this consolidated litigation in U.S. District Court for the Southern District of Illinois in which plaintiffs claimed that they suffered gall bladder injuries because they used Yaz and Yasmin as contraceptives.**

Reuters News Service reported*** that the settlements also include Yaz and Yasmin cases in state courts in California, New Jersey and Pennsylvania.

"Under the agreement, Bayer will pay $2,000 to plaintiffs who suffered gallbladder injuries and $3,000 to individuals who had their gallbladders removed, according to the agreement," Reuters reported.

"The fact that there has been a significant increase in the number of Yaz and Yasmin blood-clotting lawsuits does not preclude other consumers who may have suffered such side effects from seeking compensation in their cases," said Resource4thePeople.

"We have been receiving numerous inquiries about whether it is too late to file a Yaz or Yasmin blood-clotting lawsuit. The answer is no. However every case is different and consumers are urged to take advantage of the free consultations our national team of attorneys are offering to evaluate the legal options for any consumer."

Women who have filed Yaz and Yasmin blood-clotting lawsuits have claimed that they suffered blood clots, deep vein thrombosis, strokes and pulmonary embolisms as a result of their use of the contraceptives according to allegations contained in their lawsuits.*

Reuters in its report said that since 2009, Bayer has been hit by a wave of lawsuits claiming that the company knew or should have known of the health risks of the contraceptives and failed to warn users.

Bayer is also facing class actions lawsuits over the drugs in Canada, according to the article.

The federal court system has consolidated the thousands of Yaz and Yasmin blood-clotting lawsuits filed over claims of severe health problems into a multidistrict litigation.

Court records show that this special litigation is now in pre-trial evidence gathering and settlement talks before a federal judge who is overseeing thousands of such lawsuits in Illinois.*

Resource4thePeople also is alerting consumers to details of an April 10, 2012 Food and Drug Administration warning**** about Yaz and Yasmin blood-clotting side effects:

“The U.S. Food and Drug Administration (FDA) has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills. Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin. Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.”

In its announcement the FDA said that “The revised drug labels (Beyaz, Safyral, Yasmin and Yaz) will report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products. The labels also will include a summary of the previously released results of an FDA-funded study of the blood clot risk.”

Resource4thePeople said that additional inquiries about Yasmin and Yaz claims are coming in over news about a controversial Canadian case.

As reported by the Canadian Broadcasting Company (CBC) the British Columbia coroner’s office refused an autopsy request by the family of a woman who died from blood clots after being prescribed Yasmin.*****

The family then spent $1,200 out of their own pockets and their pathologist found that Yasmin and the woman’s obesity put her at risk of suffering the fatal blood clots, according to the report.*****

“According to the CBC the victim’s family is now seeking legal advice to determine whether they will join in the litigation against the manufacturers of Yasmin,” said Resource4thePeople. “This case involves similar allegations to those made in thousands of Yaz and Yasmin lawsuits that have been filed in the United States.

Sources:

  • In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation MDL No. 2100, U.S. District Court, Southern District of Illinois
**http://www.annualreport2012.bayer.com/en/legal-risks.aspx
***http://newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Bayer_agrees_to_settle_Yasmin,_Yaz_gallbladder_lawsuits/
****http://www.fda.gov/Drugs/DrugSafety/ucm299305.htm
*****http://www.cbc.ca/news/canada/british-columbia/story/2013/02/05/bc-coroner-bergen-yasmin.html

Read the full story at http://www.prweb.com/releases/2013/4/prweb10673957.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
2. Multiple Vaginal Mesh Lawsuits Filed Against Ethicon, Inc. on Behalf of Women Seriously Injured Allegedly Due to Vaginal Mesh Sling Defects, Reports Wright & Schulte
3. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
4. In Light of Alleged Deceptive Marketing Claims Made by Drug Makers, Parker Waichman LLP Addresses Issues Allegedly Related to the Safety and Effectiveness of Plavix
5. Skechers Fracture Lawsuit Filed on Behalf of an Arizona Woman Who Sustained Multiple Arm Fractures Allegedly Due to Unstable Shape-Ups, by Wright & Schulte
6. Vaginal Mesh Lawsuit Filed by Wright & Schulte Claims Nebraska Woman Sustained Painful Injuries Allegedly Due to Defective Vaginal Mesh Implants
7. Skechers Injury Lawsuits Filed By Wright & Schulte on Behalf of Two Consumers Who Sustained Serious Knee Injuries Allegedly Due to Wearing Shape-Ups
8. TransVaginal Mesh Lawsuit Filed on Behalf of a Georgia Woman Seriously Injured Allegedly Due to Defective TransVaginal Mesh Implants, Reports Wright & Schulte
9. Six Skechers Broken Bones Lawsuits Filed on Behalf of Consumers Who Sustained Various Bone Breaks / Fractures Allegedly Due to Design of Shape-Ups, by Wright & Schulte
10. Skechers Injury Lawsuit Filed on Behalf of a Mississippi Woman Who Suffered a Serious Knee Injury Allegedly Due to Shape-Ups’ Defective Design, by Wright & Schulte LLC
11. Multiple Skechers Lawsuits Filed on Behalf of Five Consumers Who Suffered Serious Ankle Fractures Allegedly Due to Wearing Shape-Ups, by Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... With over ... to walk, the demand for a sustainable product to aid in the rehabilitation process ... aid in the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. ... from leading advocates, associations and industry leaders such as Bioness. , As ...
(Date:5/27/2016)... ... , ... Beleza Medspa has initiated a new program to assist ... first time that Coolsculpting is being used for for more than just cosmetic purposes. ... meet the prescribed body-fat standard, measured by the circumference-based tape method. The tape-test ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 Amarantus BioScience ... on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today ... be presenting at two upcoming investor conferences: SeeThru ... Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
Breaking Medicine Technology: